Table 1.
Animal Disease Models*
SPM | Disease model | Cellular mechanism of action | References |
---|---|---|---|
Resolvin E1 | Skin | Stops neutrophil recruitment in dorsal pouch | Serhan et al.8 |
Oral inflammation, periodontitis | Reduces neutrophil infiltration; prevents connective tissue and bone loss; promotes healing of diseased tissues; regenerates lost soft tissue and bone | Hasturk et al.53 | |
Peritonitis | Stops neutrophil recruitment; regulates chemokine/cytokine production | Bannenberg et al.40; Arita et al.54; Schwab et al.55 | |
Promotes lymphatic removal of phagocytes | |||
Asthma | Reduces airway inflammation; stimulates LXA4; reduces SRS-A | Haworth et al.49 | |
Ocular | Regulates neovascularization, angiogenesis | Connor et al.51; Jin et al.56; Tian et al.57 | |
Colitis | Limits PMN recruitment and proinflammatory gene expression; improves survival; reduces weight loss | Arita et al.47; Ishida et al.58 | |
Resolvin E2 | Peritonitis | Reduces PMN infiltration | Tjonahen et al.59; Ogawa et al.60 |
Resolvin D1 | Peritonitis | Limits PMN recruitment | Hong et al.20; Sun et al.48 |
Skin | Stops PMN recruitment (air pouch) | Serhan et al.9; Hong et al.20 | |
Kidney ischemia-reperfusion | Protects from ischemia-reperfusion-induced kidney damage and loss of function; regulates macrophages and protects from fibrosis | Duffield et al.61 | |
Ocular | Protects against neovascularization | Connor et al.51 | |
Resolvin D2 | Peritonitis, sepsis | Reduce peritonitis and increase phagocyte reactive oxygen species bacterial killing | Spite et al.42 |
NPD1/Protectin D1 | Stroke | Stop leukocyte infiltration, inhibits NF-κB and cyclooxygenase-2 induction | Marcheselli et al.62,63 |
Peritonitis | Stops neutrophil recruitment; regulates chemokine/cytokine production | Bannenberg et al.40; Arita et al.54; Schwab et al.55; Ariel et al.64 | |
Promotes lymphatic removal of phagocytes | |||
Regulates T-cell migration | |||
Asthma | Protects from lung damage, airway inflammation and airway hyperresponsiveness | Levy et al.65 | |
Protectin D1 in human breath condensates appears diminished in asthmatics | |||
Kidney ischemia-reperfusion | Protects from ischemia-reperfusion-induced kidney damage and loss of function; regulates macrophages and is anti-fibrotic | Duffield et al.61; Hassan et al.66 | |
Ocular | Protects in neovascularization | Connor et al.51; Mukherjee et al.52; Sheets et al.67; He and Bazan68 | |
Protects in retinal injury | |||
Alzheimer's disease, neurodegeneration | Diminished protectin D1 production in human Alzheimer's disease | Lukiw et al.69 | |
Maresin 1 | Peritonitis | Reduces PMN migration and enhances MΦ phagocytosis | Serhan et al.21 |
SPM, specialized pro-resolving mediators.